Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The vasopressin receptor antagonist dPTyr(Me)AVP does not prevent stress-induced ACTH and corticosterone release

Abstract

Most of the experimental evidence for a role of arginine-vasopressin (AVP) in adrenocorticotropic hormone (ACTH) release comes from in vitro studies1. The multimolecular nature of the hypothalamic factor responsible for corticotropin (CRF) release has long been recognized2, but the importance of AVP as a cofactor is controversial3,4. The recently characterized 41-residue peptide5,6 fulfills the criteria for a physiological role in ACTH release7–9 and it is potentiated in vitro by AVP10,11. In vivo, AVP is able to stimulate ACTH secretion12, and Brattleboro rats, deficient in AVP, show a reduced activity of the hypothalamo-hypophysial-adrenocortical system (HHCS) (see ref. 13 for references). Direct evidence for involvement of AVP in the physiological release of ACTH is, however, still lacking. The recent development of AVP receptor antagonists14 provides the opportunity to test this hypothesis directly. I report here that pretreatment by 1-deaminopenicillamine, 2-(O-methyl)tyrosine arginine-vasopressin (dPTyr(Me)AVP), a potent antagonist of the vasopressor14,15, behavioural15 and ACTH-releasing properties of AVP16, does not modify the ACTH and corticosterone secretion induced by exposure to a novel environment, but totally inhibits the increase of ACTH and corticosterone levels induced by AVP. The results do not support the hypothesis for a physiological involvement of AVP in ACTH release.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Baertschi, A. J. & Bény, J.-L. Frontiers Horm. Res. 10, 126–140 (1982).

    Article  CAS  Google Scholar 

  2. Pearlmutter, A. F., Rapino, E. & Saffran, M. Endocrinology 97, 1336–1338 (1975).

    Article  CAS  Google Scholar 

  3. Gillies, G. & Lowry, P. Nature 278, 463–464 (1979).

    Article  ADS  CAS  Google Scholar 

  4. Pearlmutter, A. F., Dokas, L., Kong, A., Miller, R. & Saffran, M. Nature 283, 697–698 (1980).

    Article  ADS  CAS  Google Scholar 

  5. Vale, W., Spiess, J., Rivier, C. & Rivier, J. Science 213, 1394–1397 (1981).

    Article  ADS  CAS  Google Scholar 

  6. Spiess, J., Rivier, J., Rivier, C. & Vale, W. Proc. natn. Acad. Sci. U.S.A. 78, 6517–6521 (1981).

    Article  ADS  CAS  Google Scholar 

  7. Rivier, C., Brownstein, M., Spiess, J., Rivier, J. & Vale, W. Endocrinology 110, 272–278 (1982).

    Article  CAS  Google Scholar 

  8. Sueiras-Diaz, J. et al. Life Sci. 31, 429–435 (1982).

    Article  CAS  Google Scholar 

  9. Hook, V. Y. H., Heisler, S., Sabol, S. L. & Axelrod, J. Biochem. biophys. Res. Commun. 106, 1364–1371 (1982).

    Article  CAS  Google Scholar 

  10. Gillies, G. E., Linton, E. A. & Lowry, P. J. Nature 299, 355–357 (1982).

    Article  ADS  CAS  Google Scholar 

  11. Turkelson, C. M. et al. Peptides 1, 111–113 (1982).

    Article  Google Scholar 

  12. Yasuda, N., Greer, M. A., Greer, S. E. & Panton, P. Endocrinology 103, 906–911 (1978).

    Article  CAS  Google Scholar 

  13. Conte-Devolx, B. et al. Endocrinology 110, 2097–2100 (1982).

    Article  CAS  Google Scholar 

  14. Bankowski, K., Manning, M., Haldar, J. & Sawyer, W. H. J. med. Chem. 21, 850–853 (1978).

    Article  CAS  Google Scholar 

  15. Le Moal, M. et al. Nature 291, 491–493 (1981).

    Article  ADS  CAS  Google Scholar 

  16. Aizawa, T., Yasuda, N., Greer, M. A. & Sawyer, W. H. Endocrinology 110, 98–104 (1982).

    Article  CAS  Google Scholar 

  17. Mason, J. W. J. psychiat. Res. 8, 323–333 (1971).

    Article  CAS  Google Scholar 

  18. Murphy, B. E. P. J. clin. Endocr. Metab. 27, 973–990 (1967).

    Article  CAS  Google Scholar 

  19. Britton, D. R., Koob, G. F., Rivier, J. & Vale, W. Life Sci. 31, 363–367 (1982).

    Article  CAS  Google Scholar 

  20. Wood, C. E., Shinsako, J., Keil, L. C., Ramsay, D. J. & Dallman, M. F. Endocrinology 110, 1416–1421 (1982).

    Article  CAS  Google Scholar 

  21. Koob, G. F. et al. Regulat. Peptides 2, 153–163 (1981).

    Article  CAS  Google Scholar 

  22. Kasting, N. W., Veale, W. L. & Cooper, K. E. Neurosci. Biobehav. Rev. 6, 215–222 (1982).

    Article  CAS  Google Scholar 

  23. Husain, M. K., Manger, W. M., Rock, T. W., Weiss, R. J. & Frantz, A.-G. Endocrinology 104, 641–644 (1979).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mormède, P. The vasopressin receptor antagonist dPTyr(Me)AVP does not prevent stress-induced ACTH and corticosterone release. Nature 302, 345–346 (1983). https://doi.org/10.1038/302345a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/302345a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing